Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Anemia Management in Surgical Oncology
NCT05505006Phase 4Unknown
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Mar 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric carboxymaltose in anemia, sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoints: Change in transfusion number compared to a historical cohort, Change in short-term (30 days) patients' outcomes and 2 more. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05505006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05505006.